Amgen Announces Positive Topline Phase 2 Results For Investigati

AMGN: Amgen
2020-10-05 16:30:00
Amgen Announces Positive Topline Phase 2 Results For Investigational KRAS G12C Inhibitor Sotorasib In Advanced Non-Small Cell Lung Cancer
Beyond Technical Analysis

Clause de non-responsabilité